Cabaletta Bio (CABA)
US Market

Cabaletta Bio (CABA) Financial Statements


Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-1.776; its P/E ratio is -6.96; Cabaletta Bio is scheduled to report earnings on March 15, 2023, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -11.78M$ -13.06M$ -13.00M$ -13.89M$ -11.56M
EBITDA$ -11.41M$ -12.82M$ -12.78M$ -13.66M$ -11.34M
Net Income Common Stockholders$ -11.43M$ -11.31M$ -12.95M$ -13.89M$ -11.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 85.89M$ 96.81M$ 109.21M$ 122.22M$ 119.26M
Total Assets$ 91.67M$ 102.02M$ 113.66M$ 126.34M$ 122.64M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -85.89M$ -96.81M$ -109.21M$ -122.22M$ -119.26M
Total Liabilities$ 5.80M$ 6.49M$ 6.93M$ 8.38M$ 6.02M
Stockholders Equity$ 85.87M$ 95.53M$ 106.72M$ 117.96M$ 116.61M
Cash Flow-
Free Cash Flow$ -11.01M$ -12.42M$ -12.96M$ -10.67M$ -8.87M
Operating Cash Flow$ -9.91M$ -11.53M$ -12.81M$ -10.52M$ -8.34M
Investing Cash Flow$ 23.91M$ -898.00K$ -49.91M$ 849.00K$ 1.77M
Financing Cash Flow$ 0.00$ 40.00K$ 51.00K$ 13.63M$ 25.34M
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis